DNA Vaccination With Hsp70 Protects Against Systemic Lupus Erythematosus in (NZB × NZW)F1 Mice. Issue 6 (30th April 2020)

• Record Type: Journal Article
• Authors: Liu, Aijing; Ferretti, Concetta; Shi, Fu‐Dong; Cohen, Irun R.; Quintana, Francisco J.; La Cava, Antonio
• Is Part Of: Arthritis & rheumatology. Volume 72:Issue 6(2020)
• Page Start: 997
• Page End: 1002
• Publication Date: 2020-04-30
• Subjects: Arthritis -- Periodicals; Rheumatism -- Periodicals; 616.72
• DOI: 10.1002/art.41202
• Languages: English
• ISSNs: 2326-5191

Abstract

Abstract : Objective: To address whether a targeted modulation of the abnormal expression of Hsp70 and autoantibodies against this molecule in systemic lupus erythematosus can influence disease. Methods: Lupus‐prone (NZB × NZW)F1 mice that had been DNA‐vaccinated with plasmids encoding Hsp70 and controls were monitored for lupus disease parameters including anti–double stranded DNA (anti‐dsDNA) autoantibodies and cytokines using enzyme‐linked immunosorbent assay, and for kidney function and pathology. The phenotypic and numerical changes in relevant immune cells were evaluated by flow cytometry, and cell function was assessed. Results: Mice that had been DNA‐vaccinated with Hsp70 displayed marked suppression of anti‐dsDNA antibody production, reduced renal disease, and antiinflammatory responses that are associated with a significantly extended survival, compared to controls. These protective effects in Hsp70‐vaccinated mice were associated with an induction of tolerogenic immune responses and an expansion of functional Treg cells. Conclusion: DNA vaccination with Hsp70 suppresses murine lupus by inducing tolerogenic immune responses and antiinflammatory immune responses associated with reduced disease manifestations and increased mouse survival.